Risk factors for mortality in AAV-ILD included age, a history of smoking, a UIP pattern, acute exacerbations of ILD, and the microscopic polyangiitis subtype.

Icotrokinra appears to be an effective treatment for adolescents with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

Children born to anti-Ro antibody-positive mothers do not exhibit a greater prevalence of allergic, neurodevelopmental, or autoimmune conditions.

The FDA has approved a prefilled syringe formulation of Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) that allows patients to self-inject the medication.

The inability to pay for health care has reached its highest point in the United States, according to the results of a survey.

The American Society of Clinical Oncology presents updated recommendations for fertility preservation (FP) in people with cancer.

People covered by Medicaid are just as likely as those with private insurance to face a copay or other charge for sending a message to their physician or other provider through a portal.

All-cause mortality increased in 2020 to 2021 nationwide, with a slower increase in Medicaid expansion states, according to a study.

Patients with gout living in rural vs urban areas face a significantly higher risk for MI-related hospitalization.

Long-term treatment with mepolizumab, an interleukin-5 inhibitor, demonstrates a favorable safety profile and sustained corticosteroid-sparing benefits among patients with eosinophilic granulomatosis ...

Treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs) may reduce the risk of dementia or cognitive impairment.

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.